Page last updated: 2024-12-05

captan

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Captan is a fungicide, chemically known as N-(trichloromethylthio)-4-cyclohexene-1,2-dicarboximide. It is synthesized by reacting tetrachloromethane with N-(mercaptomethyl)-cyclohexene-1,2-dicarboximide. Captan has been widely used to control a range of fungal diseases in various crops, including fruits, vegetables, and ornamentals. Its mode of action involves inhibiting fungal growth by interfering with the synthesis of essential proteins. Due to its effectiveness and broad-spectrum activity, captan has been extensively studied. However, concerns have been raised about its potential environmental and health risks, including its persistence in the environment and its potential to be carcinogenic. Research continues to investigate its effects on human health, wildlife, and the environment to understand its long-term implications and develop alternative fungicides.'

Captan: One of the phthalimide fungicides. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

captan : A dicarboximide that is 3a,4,7,7a-tetrahydrophthalimide in which the hydrogen attached to the nitrogen is replaced by a trichloromethyl group. A non-systemic fungicide introduced in the 1950s, it is widely used for the control of fungal diseases in fruits, vegetables, and ornamental crops. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID8606
CHEMBL ID388676
CHEBI ID34608
SCHEMBL ID21047
MeSH IDM0003318

Synonyms (142)

Synonym
n-[(trichloromethyl)thio]-4-cyclohexene-1,2-dicarboximide
captaf
orthocid-83
flit 406
n-[(trichloromethyl)thio]cyclohex-4-ene-1,2-dicarboximide
4-cyclohexene-1, n-(trichloromethylthio)-
n-[(trichloromethyl)mercapto]-.delta.(sup 4)-tetrahydrophthalimide
captex
aacaptan
wln: t56 bvnv gutj csxggg
orthocide 406
vondcaptan
esso fungicide 406
kaptan
vancide 89re
vancide 89
malipur
sr 406
orthocide 7.5
n-[(trichloromethyl)thio]tetrahydrophthalimide
orthocide
merpan
captan
1h-isoindole-1, 3a,4,7,7a-tetrahydro-2-[(trichloromethyl)thio]-
n-[(trichloromethyl)thio]-cis-.delta.(sup 4)-cyclohexene-1,2-dicarboximide
nci-c00077
ortocid 50
captan 50w
sr406
ent 26,538
n-[(trichloromethyl)mercapto]-4-cyclohexene-1,2-dicarboximide
neracid
glyodex 37-22
vangard k
stauffer captan
orthocide 83
orthocide 50
fungus ban type ii
nsc36726
le captane
n-trichloromethylthio-3a,7,7a-tetrahydrophthalimide
133-06-2
captaf 85w
orthocide 75
4-cyclohexene-1, n-[(trichloromethyl)thio]-
captane
nsc-36726
amercide
2-[(trichloromethyl)thio]-3a,4,7,7a-tetrahydro-1h-isoindole-1,3(2h)-dione
4-cyclohexene-1,2-dicarboximide, n-[(trichloromethyl)thio]-
1h-isoindole-1,3(2h)-dione, 3a,4,7,7a-tetrahydro-2-[(trichloromethyl)thio]-
NCGC00091034-01
NCGC00091034-02
micro-check 12
bangton
3a,4,7,7a-tetrahydro-2-((trichloromethyl)thio)-1h-isoindole-1,3(2h)-dione
n-trichloromethylthiocyclohex-4-ene-1,2-dicarboximide
n-trichloromethylmercapto-4-cyclohexene-1,2-dicarboximide
captan-streptomycin 7.5-0.1 potato seed piece protectant
3a,4,7,7a-tetrahydro-n-(trichloromethanesulphenyl)phthalimide
captab
captancapteneet 26,538
kaptazor
gustafson captan 30-dd
vanguard k
3a,4,7,7a-tetrahydro-2-[(trichloromethyl)thio]-1h-isoindole-1,3(2h)-dione
vancide p-75
n-trichloromethylthio-3a,4,7,7a-tetrahydrophthalimide
trichloromethylthio-1,2,5,6-tetrahydrophthalamide
hexacap
agrosol s
granox pfm
osocide
trimegol
agrox 2-way and 3-way
captadin
vanicide
ugecap
captanex
bean seed protectant
NCGC00091034-03
NCGC00091034-04
n-(trichloromethylthio)-4-cyclohexene-1,2-dicarboximide
C2059
smr001307282
MLS002222339
chebi:34608 ,
CHEMBL388676
2-(trichloromethylsulfanyl)-3a,4,7,7a-tetrahydroisoindole-1,3-dione
ldvvmczrfwmzsg-uhfffaoysa-
inchi=1/c9h8cl3no2s/c10-9(11,12)16-13-7(14)5-3-1-2-4-6(5)8(13)15/h1-2,5-6h,3-4h2
NCGC00091034-07
NCGC00091034-06
NCGC00091034-05
NCGC00091034-09
NCGC00091034-08
tox21_201276
NCGC00258828-01
NCGC00254676-01
tox21_300772
dtxsid9020243 ,
dtxcid90243
tox21_111065
cas-133-06-2
trichlormethylthioamid kyseliny 1,2,3,6-tetrahydroftalove
n-(trichlor-methylthio)-phthalimid
FT-0602921
AKOS015895773
SCHEMBL21047
mfcd00041811
venturin
zenecal
n-(trichloromethylmercapto)-delta(4)-tetrahydrophthalimide
2-[(trichloromethyl)sulfanyl]-3a,4,7,7a-tetrahydro-1h-isoindole-1,3(2h)-dione
NCGC00091034-10
n-((trichloromethyl)thio)-4-cyclohexene-1,2-dicarboximide
n-((trichloromethyl)thio)cyclohex-4-ene-1,2-dicarboximide
bangtan
n-trichloromethyl-thio-3a,4,7,7a-tetrahydropthalimide
orthocide s 50
3a,4,7,7a-tetrahydro-2-[(trichloromethyl)thio]-1h-isoindole-1,3(2h)dione
n-[(trichloromethyl)thio]-.delta.4-tetrahydrophthalimide
n-((trichloromethyl)mercapto)-.delta.4-tetrahydrophthalimide
n-((trichloromethyl)mercapto)-4-cyclohexene-1,2-dicarboximide
orthocide-83
2-[(trichloromethyl)sulfanyl]-3a,4,7,7a-tetrahydro-1h-isoindole-1,3(2h)-dione #
CCG-231621
2-((trichloromethyl)thio)-3a,4,7,7a-tetrahydro-1h-isoindole-1,3(2h)-dione
1h-isoindole-1,3(2h)-dione,3a,4,7,7a-tetrahydro-2-[(trichloromethyl)thio]-
captan, pestanal(r), analytical standard
captan, analytical standard
captan 100 microg/ml in acetonitrile
J-006299
captan, certified reference material, tracecert(r)
Q2194382
AS-13811
CS-0013481
AMY40937
captan 1000 microg/ml in acetone
D89482
HY-B1584
captan 100 microg/ml in acetone

Research Excerpts

Overview

Captan is a widely used antifungal pesticide whose potential to cause cancer in humans is uncertain. Captan is an important fungicide for controlling diseases in horticultural crops.

ExcerptReferenceRelevance
"Captan is a non-systematic fungicide widely used in agricultural production, and its residues have been found in the environment and daily diet. "( Captan exposure disrupts ovarian homeostasis and affects oocytes quality via mitochondrial dysfunction induced apoptosis.
He, QK; Li, YP; Liu, Y; Luo, YS; Qi, ZQ; Wang, HL; Xu, CL; Xu, ZR; Zhao, SC, 2022
)
3.61
"Captan is a widely used antifungal pesticide whose potential to cause cancer in humans is uncertain."( Cancer incidence among pesticide applicators exposed to captan in the Agricultural Health Study.
Alavanja, MC; Dosemeci, M; Greenburg, DL; Hines, CJ; Hoppin, JA; Koutros, S; Patel, R; Rusiecki, J, 2008
)
2.03
"Captan is an important fungicide for controlling diseases in horticultural crops. "( The effects of temperature, humidity and rainfall on captan decline on apple leaves and fruit in controlled environment conditions.
Hyder, K; Murray, RA; Salazar, JD; Xu, XM, 2008
)
2.04
"Captan is an important fungicide for controlling diseases in horticultural crops. "( The temporal pattern of captan residues on apple leaves and fruit under field conditions in relation to weather and canopy structure.
Hyder, K; Murray, RA; Salazar, JD; Xu, XM, 2008
)
2.1

Effects

ExcerptReferenceRelevance
"Captan has become an increasingly important fungicide in the management of common apple diseases such as apple scab (Venturia inaequalis) and bitter rot (Colletotrichum spp.) due to the low risk of fungicide resistance evolving in either pathogen population to this product. "( Incorporating Adjuvants with Captan to Manage Common Apple Diseases.
Abbott, CP; Beckerman, JL, 2018
)
2.21

Treatment

Captan treatment resulted in production of DNA single strand breaks and DNA-protein cross-links. Captan-treated male rats were more susceptible to the induction of chronic renal disease than were female rats.

ExcerptReferenceRelevance
"Captan treatment resulted in production of DNA single strand breaks and DNA-protein cross-links and elicited an excision repair response in human diploid fibroblasts."( Effects of Captan on DNA and DNA metabolic processes in human diploid fibroblasts.
Snyder, RD, 1992
)
1.39
"Captan-treated male rats were more susceptible to the induction of chronic renal disease than were female rats."( Carcinogenicity of captan.
Reuber, MD,
)
1.18

Toxicity

Captan is relatively nontoxic, but it can be extremely toxic after parenteral exposure. The fungicides captan and thiram were the most toxic among the compounds tested.

ExcerptReferenceRelevance
" The relative toxic potency of aldrin fenvalerate, captan and diazinon was in a ratio of 6807:241:4:1 respectively."( Relative toxicity of aldrin, fenvalerate, captan and diazinon to the freshwater food-fish, Clarias batrachus.
Tripathi, G, 1992
)
0.8
" The fungicides captan and thiram were the most toxic among the compounds tested."( 1,8-Naphthalic anhydride antidote enhances the toxic effects of captan and thiram fungicides on Azospirillum brasilense cells.
Casalone, E; Colella, CM; Daly, S; Gallori, E; Polsinelli, M,
)
0.72
"If given orally captan is relatively nontoxic, but it can be extremely toxic after parenteral exposure."( Involvement of glutathione in the reduction of captan-induced in vivo inhibition of monooxygenases and liver toxicity in the rat.
Dalvi, RR, 1988
)
0.88
" There may also be an impact at greater distances from treated plots, especially in the case of compounds that are slow to degrade such as MITC (methyl isothiocyanate), the active toxic moiety generated in soil from metham sodium."( Possible side effects of airborne pesticides on fungi and vascular plants in The Netherlands.
Canters, KJ; de Jong, FM; van der Voet, E, 1995
)
0.29
" Toxic effects on survival, motility, and growth decreased with increasing pH."( Toxic effects, at three pH levels, of two reference molecules on common carp embryo.
Chaillou, C; Deschamps, F; Ghillebaert, F; Roubaud, P, 1995
)
0.29
" The toxic and genotoxic potentials of captan were evaluated with the micronucleus test (MNT; AFNOR,2000) and the comet assay (CA) using amphibian larvae (Xenopus laevis and Pleurodeles waltl)."( Comparative evaluation of genotoxicity of captan in amphibian larvae (Xenopus laevis and Pleurodeles waltl) using the comet assay and the micronucleus test.
Devaux, A; Ferrier, V; Gauthier, L; Mailhes, C; Mouchet, F, 2006
)
0.87
" obliquus accumulated more captan, but efficiently degraded it into two safe eco-friendly by-products; phthalic acid and 1,2,3,6-tetrahydro phthalimide."( Evaluation of the phycoremediation potential of microalgae for captan removal: Comprehensive analysis on toxicity, detoxification and antioxidants modulation.
AbdElgawad, H; Al-Saadi, LS; Hamed, SM; Hozzein, WN; Mohamed, HS; Okla, MK; Selim, S, 2022
)
1.26

Compound-Compound Interactions

ExcerptReferenceRelevance
" The obtained results show that the DLLME combined with GC-ECD can satisfy the requirements for the determination of fungicides in apple samples."( Analysis of captan, folpet, and captafol in apples by dispersive liquid-liquid microextraction combined with gas chromatography.
Ma, J; Wang, J; Wang, M; Wang, O; Wang, Z; Xi, G; Zang, X, 2008
)
0.72
" A fast and non-destructive analysis method, combined with a GA and SVM based on fluorescence spectroscopy, was realized."( Detection of captan residues in apple juice using fluorescence spectroscopy combined with a genetic algorithm and support vector machines.
Bian, H; Han, Y; Ji, R; Jiang, Z; Wang, X; Yang, Y; Zhang, Y; Zhuang, L, 2022
)
1.09

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51

Dosage Studied

DNA purified from the liver, stomach, duodenum and jejenum of mice dosed with 35S radiolabelled captan was found to contain radioactivity equivalent to Covalent Binding Indices in the range 38-91. DNA from the bone marrow had a CBI of 2.

ExcerptRelevanceReference
" Furthermore, usual increase in the activity of drug biotransformation enzymes seen after phenobarbital treatment appears to decrease in rats dosed with this funaicide."( Toxicologic studies of N-trichloromethylthio-4-cyclohexene-1,2-dicarboximide (captan): its metabolism by rat liver drug-metabolizing enzyme system.
Dalvi, RR; Peeples, A, 1978
)
0.49
" The percentage penetration was found to increase as dosage (0."( Dermal penetration of [14C]captan in young and adult rats.
Fisher, HL; Hall, LL; Shah, PV; Sumler, MR, 1992
)
0.58
" It was also demonstrated that captan was mutagenic to cells of the mouse testis; there was a certain relationship between dosage and response."( Cytogenetic effects of an agricultural antibiotic, captan, on mouse bone marrow and testicular cells.
Feng, JY; Lin, BY, 1987
)
0.81
" acutatum, Botrytis cinerea, Fusarium oxysporum, Phomopsis obscurans, and Phomopsis viticola) in in vitro dose-response studies."( Isolation and identification of antifungal fatty acids from the basidiomycete Gomphus floccosus.
Cantrell, CL; Case, BP; Duke, SO; Kniffin, TM; Mena, EE; Wedge, DE, 2008
)
0.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
antifungal agrochemicalAny substance used in acriculture, horticulture, forestry, etc. for its fungicidal properties.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (4)

ClassDescription
isoindoles
organochlorine compoundAn organochlorine compound is a compound containing at least one carbon-chlorine bond.
organosulfur compoundAn organosulfur compound is a compound containing at least one carbon-sulfur bond.
phthalimide fungicideA dicarboximide fungicide whose structure contains a phthalimide derivative.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (96)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, HADH2 proteinHomo sapiens (human)Potency10.59390.025120.237639.8107AID886; AID893
Chain B, HADH2 proteinHomo sapiens (human)Potency10.59390.025120.237639.8107AID886; AID893
LuciferasePhotinus pyralis (common eastern firefly)Potency24.13580.007215.758889.3584AID1224835; AID624030
interleukin 8Homo sapiens (human)Potency70.90110.047349.480674.9780AID651758
acetylcholinesteraseHomo sapiens (human)Potency72.66330.002541.796015,848.9004AID1347397; AID1347398; AID1347399
15-lipoxygenase, partialHomo sapiens (human)Potency1.00000.012610.691788.5700AID887
pregnane X receptorRattus norvegicus (Norway rat)Potency44.66840.025127.9203501.1870AID651751
phosphopantetheinyl transferaseBacillus subtilisPotency7.28210.141337.9142100.0000AID1490; AID2701; AID2707
hypoxia-inducible factor 1 alpha subunitHomo sapiens (human)Potency34.06783.189029.884159.4836AID1224846; AID1224894
RAR-related orphan receptor gammaMus musculus (house mouse)Potency18.41740.006038.004119,952.5996AID1159521; AID1159523
SMAD family member 2Homo sapiens (human)Potency13.57800.173734.304761.8120AID1346924
USP1 protein, partialHomo sapiens (human)Potency70.79460.031637.5844354.8130AID504865
GLS proteinHomo sapiens (human)Potency14.12540.35487.935539.8107AID624170
SMAD family member 3Homo sapiens (human)Potency13.57800.173734.304761.8120AID1346924
TDP1 proteinHomo sapiens (human)Potency0.70910.000811.382244.6684AID686978; AID686979
GLI family zinc finger 3Homo sapiens (human)Potency4.21830.000714.592883.7951AID1259369; AID1259392
AR proteinHomo sapiens (human)Potency18.15270.000221.22318,912.5098AID1259243; AID1259247; AID588515; AID588516; AID743035; AID743036; AID743042; AID743054; AID743063
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency0.48020.011212.4002100.0000AID1030
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)Homo sapiens (human)Potency35.71680.00137.762544.6684AID2120
thyroid stimulating hormone receptorHomo sapiens (human)Potency8.97160.001318.074339.8107AID926; AID938
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency13.80840.000657.913322,387.1992AID1259377; AID1259378
hypothetical protein, conservedTrypanosoma bruceiPotency14.12540.223911.245135.4813AID624173
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency19.19760.001022.650876.6163AID1224838; AID1224839; AID1224893
progesterone receptorHomo sapiens (human)Potency42.57390.000417.946075.1148AID1346795
cytochrome P450 family 3 subfamily A polypeptide 4Homo sapiens (human)Potency13.65250.01237.983543.2770AID1346984; AID1645841
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency29.84990.000214.376460.0339AID588532; AID588533; AID720691; AID720692; AID720719
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency11.84140.003041.611522,387.1992AID1159552; AID1159553; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency15.43620.000817.505159.3239AID1159527; AID1159531; AID588544; AID588546
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency34.29510.001530.607315,848.9004AID1224841; AID1224842; AID1224848; AID1224849; AID1259401; AID1259403
farnesoid X nuclear receptorHomo sapiens (human)Potency41.70980.375827.485161.6524AID588526; AID588527; AID743217; AID743220
pregnane X nuclear receptorHomo sapiens (human)Potency24.37260.005428.02631,258.9301AID1346982; AID720659
estrogen nuclear receptor alphaHomo sapiens (human)Potency32.73350.000229.305416,493.5996AID1259244; AID1259248; AID1259383; AID588513; AID588514; AID743069; AID743075; AID743078; AID743079; AID743080; AID743091
GVesicular stomatitis virusPotency6.74120.01238.964839.8107AID1645842
cytochrome P450 2D6Homo sapiens (human)Potency18.99910.00108.379861.1304AID1645840
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency21.68200.001024.504861.6448AID588534; AID588535; AID743215
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency22.06220.001019.414170.9645AID588536; AID588537; AID743094; AID743140; AID743191
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency15.32690.023723.228263.5986AID588541; AID588543; AID743222; AID743223; AID743241
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency1.58490.035520.977089.1251AID504332
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)Homo sapiens (human)Potency14.12540.016525.307841.3999AID602332
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency5.90340.001723.839378.1014AID743083
thyroid stimulating hormone receptorHomo sapiens (human)Potency39.76760.001628.015177.1139AID1224843; AID1224895; AID1259385; AID1259395
activating transcription factor 6Homo sapiens (human)Potency60.65060.143427.612159.8106AID1159516
thyrotropin-releasing hormone receptorHomo sapiens (human)Potency33.28120.154917.870243.6557AID1346877
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency38.267919.739145.978464.9432AID1159509
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency12.22850.057821.109761.2679AID1159526; AID1159528
nuclear receptor subfamily 1, group I, member 2Rattus norvegicus (Norway rat)Potency17.78280.10009.191631.6228AID1346983
Histone H2A.xCricetulus griseus (Chinese hamster)Potency59.04800.039147.5451146.8240AID1224845
cellular tumor antigen p53 isoform aHomo sapiens (human)Potency31.62280.316212.443531.6228AID902
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1Homo sapiens (human)Potency7.51140.001815.663839.8107AID894
vitamin D3 receptor isoform VDRAHomo sapiens (human)Potency3.98110.354828.065989.1251AID504847
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency26.14050.010039.53711,122.0200AID588545; AID588547
potassium voltage-gated channel subfamily H member 2 isoform dHomo sapiens (human)Potency28.30850.01789.637444.6684AID588834
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency20.93890.000323.4451159.6830AID743065; AID743066; AID743067
heat shock protein beta-1Homo sapiens (human)Potency19.59650.042027.378961.6448AID743210; AID743228
huntingtin isoform 2Homo sapiens (human)Potency14.12540.000618.41981,122.0200AID1688
mitogen-activated protein kinase 1Homo sapiens (human)Potency15.84890.039816.784239.8107AID995
nuclear factor NF-kappa-B p105 subunit isoform 1Homo sapiens (human)Potency35.71684.466824.832944.6684AID651749
histone-lysine N-methyltransferase 2A isoform 2 precursorHomo sapiens (human)Potency39.81070.010323.856763.0957AID2662
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency38.09490.000627.21521,122.0200AID651741; AID720636; AID743202; AID743219
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency1.68100.00798.23321,122.0200AID2546; AID2551
gemininHomo sapiens (human)Potency5.45050.004611.374133.4983AID624296; AID624297
peripheral myelin protein 22Rattus norvegicus (Norway rat)Potency17.59400.005612.367736.1254AID624032; AID624044
cytochrome P450 3A4 isoform 1Homo sapiens (human)Potency14.21910.031610.279239.8107AID884; AID885
histone acetyltransferase KAT2A isoform 1Homo sapiens (human)Potency39.81070.251215.843239.8107AID504327
lethal factor (plasmid)Bacillus anthracis str. A2012Potency6.58120.020010.786931.6228AID912
lamin isoform A-delta10Homo sapiens (human)Potency0.79430.891312.067628.1838AID1487
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)Potency14.21911.000012.224831.6228AID885
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency26.86230.001557.789015,848.9004AID1259244
Interferon betaHomo sapiens (human)Potency6.74120.00339.158239.8107AID1645842
HLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)Potency6.74120.01238.964839.8107AID1645842
Cellular tumor antigen p53Homo sapiens (human)Potency29.97760.002319.595674.0614AID651631; AID651743; AID720552
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)Potency14.21911.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)Potency14.21911.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)Potency14.21911.000012.224831.6228AID885
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency26.86230.001551.739315,848.9004AID1259244
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)Potency14.21911.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)Potency14.21911.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)Potency14.21911.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)Potency14.21911.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)Potency14.21911.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)Potency14.21911.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)Potency14.21911.000012.224831.6228AID885
Nuclear receptor ROR-gammaHomo sapiens (human)Potency5.44940.026622.448266.8242AID651802
Spike glycoproteinSevere acute respiratory syndrome-related coronavirusPotency11.22020.009610.525035.4813AID1479145
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)Potency14.21911.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)Potency14.21911.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)Potency14.21911.000012.224831.6228AID885
GABA theta subunitRattus norvegicus (Norway rat)Potency14.21911.000012.224831.6228AID885
Inositol hexakisphosphate kinase 1Homo sapiens (human)Potency6.74120.01238.964839.8107AID1645842
ATPase family AAA domain-containing protein 5Homo sapiens (human)Potency42.37340.011917.942071.5630AID651632; AID720516
Ataxin-2Homo sapiens (human)Potency46.81440.011912.222168.7989AID651632
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)Potency14.21911.000012.224831.6228AID885
cytochrome P450 2C9, partialHomo sapiens (human)Potency6.74120.01238.964839.8107AID1645842
ATP-dependent phosphofructokinaseTrypanosoma brucei brucei TREU927Potency28.18380.060110.745337.9330AID492961
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Replicase polyprotein 1abBetacoronavirus England 1IC50 (µMol)10.00000.00403.43889.5100AID1640022
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2IC50 (µMol)0.67000.00022.45859.9600AID1640021
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (195)

Processvia Protein(s)Taxonomy
cell surface receptor signaling pathway via JAK-STATInterferon betaHomo sapiens (human)
response to exogenous dsRNAInterferon betaHomo sapiens (human)
B cell activation involved in immune responseInterferon betaHomo sapiens (human)
cell surface receptor signaling pathwayInterferon betaHomo sapiens (human)
cell surface receptor signaling pathway via JAK-STATInterferon betaHomo sapiens (human)
response to virusInterferon betaHomo sapiens (human)
positive regulation of autophagyInterferon betaHomo sapiens (human)
cytokine-mediated signaling pathwayInterferon betaHomo sapiens (human)
natural killer cell activationInterferon betaHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylation of STAT proteinInterferon betaHomo sapiens (human)
cellular response to interferon-betaInterferon betaHomo sapiens (human)
B cell proliferationInterferon betaHomo sapiens (human)
negative regulation of viral genome replicationInterferon betaHomo sapiens (human)
innate immune responseInterferon betaHomo sapiens (human)
positive regulation of innate immune responseInterferon betaHomo sapiens (human)
regulation of MHC class I biosynthetic processInterferon betaHomo sapiens (human)
negative regulation of T cell differentiationInterferon betaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIInterferon betaHomo sapiens (human)
defense response to virusInterferon betaHomo sapiens (human)
type I interferon-mediated signaling pathwayInterferon betaHomo sapiens (human)
neuron cellular homeostasisInterferon betaHomo sapiens (human)
cellular response to exogenous dsRNAInterferon betaHomo sapiens (human)
cellular response to virusInterferon betaHomo sapiens (human)
negative regulation of Lewy body formationInterferon betaHomo sapiens (human)
negative regulation of T-helper 2 cell cytokine productionInterferon betaHomo sapiens (human)
positive regulation of apoptotic signaling pathwayInterferon betaHomo sapiens (human)
response to exogenous dsRNAInterferon betaHomo sapiens (human)
B cell differentiationInterferon betaHomo sapiens (human)
natural killer cell activation involved in immune responseInterferon betaHomo sapiens (human)
adaptive immune responseInterferon betaHomo sapiens (human)
T cell activation involved in immune responseInterferon betaHomo sapiens (human)
humoral immune responseInterferon betaHomo sapiens (human)
positive regulation of T cell mediated cytotoxicityHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
adaptive immune responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independentHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of T cell anergyHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
defense responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
immune responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
detection of bacteriumHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of interleukin-12 productionHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of interleukin-6 productionHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
protection from natural killer cell mediated cytotoxicityHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
innate immune responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of dendritic cell differentiationHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
antigen processing and presentation of endogenous peptide antigen via MHC class IbHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycle G2/M phase transitionCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
ER overload responseCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
mitophagyCellular tumor antigen p53Homo sapiens (human)
in utero embryonic developmentCellular tumor antigen p53Homo sapiens (human)
somitogenesisCellular tumor antigen p53Homo sapiens (human)
release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
hematopoietic progenitor cell differentiationCellular tumor antigen p53Homo sapiens (human)
T cell proliferation involved in immune responseCellular tumor antigen p53Homo sapiens (human)
B cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
T cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
response to ischemiaCellular tumor antigen p53Homo sapiens (human)
nucleotide-excision repairCellular tumor antigen p53Homo sapiens (human)
double-strand break repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
protein import into nucleusCellular tumor antigen p53Homo sapiens (human)
autophagyCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorCellular tumor antigen p53Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
Ras protein signal transductionCellular tumor antigen p53Homo sapiens (human)
gastrulationCellular tumor antigen p53Homo sapiens (human)
neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
protein localizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA replicationCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
determination of adult lifespanCellular tumor antigen p53Homo sapiens (human)
mRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
rRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
response to salt stressCellular tumor antigen p53Homo sapiens (human)
response to inorganic substanceCellular tumor antigen p53Homo sapiens (human)
response to X-rayCellular tumor antigen p53Homo sapiens (human)
response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
positive regulation of gene expressionCellular tumor antigen p53Homo sapiens (human)
cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
viral processCellular tumor antigen p53Homo sapiens (human)
glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
cerebellum developmentCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell growthCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCellular tumor antigen p53Homo sapiens (human)
negative regulation of telomere maintenance via telomeraseCellular tumor antigen p53Homo sapiens (human)
T cell differentiation in thymusCellular tumor antigen p53Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
regulation of tissue remodelingCellular tumor antigen p53Homo sapiens (human)
cellular response to UVCellular tumor antigen p53Homo sapiens (human)
multicellular organism growthCellular tumor antigen p53Homo sapiens (human)
positive regulation of mitochondrial membrane permeabilityCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
entrainment of circadian clock by photoperiodCellular tumor antigen p53Homo sapiens (human)
mitochondrial DNA repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
transcription initiation-coupled chromatin remodelingCellular tumor antigen p53Homo sapiens (human)
negative regulation of proteolysisCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of RNA polymerase II transcription preinitiation complex assemblyCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
response to antibioticCellular tumor antigen p53Homo sapiens (human)
fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
circadian behaviorCellular tumor antigen p53Homo sapiens (human)
bone marrow developmentCellular tumor antigen p53Homo sapiens (human)
embryonic organ developmentCellular tumor antigen p53Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationCellular tumor antigen p53Homo sapiens (human)
protein stabilizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of helicase activityCellular tumor antigen p53Homo sapiens (human)
protein tetramerizationCellular tumor antigen p53Homo sapiens (human)
chromosome organizationCellular tumor antigen p53Homo sapiens (human)
neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
hematopoietic stem cell differentiationCellular tumor antigen p53Homo sapiens (human)
negative regulation of glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
type II interferon-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cardiac septum morphogenesisCellular tumor antigen p53Homo sapiens (human)
positive regulation of programmed necrotic cell deathCellular tumor antigen p53Homo sapiens (human)
protein-containing complex assemblyCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressCellular tumor antigen p53Homo sapiens (human)
thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
necroptotic processCellular tumor antigen p53Homo sapiens (human)
cellular response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
cellular response to xenobiotic stimulusCellular tumor antigen p53Homo sapiens (human)
cellular response to ionizing radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to UV-CCellular tumor antigen p53Homo sapiens (human)
stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
cellular response to actinomycin DCellular tumor antigen p53Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
cellular senescenceCellular tumor antigen p53Homo sapiens (human)
replicative senescenceCellular tumor antigen p53Homo sapiens (human)
oxidative stress-induced premature senescenceCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
oligodendrocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of execution phase of apoptosisCellular tumor antigen p53Homo sapiens (human)
negative regulation of mitophagyCellular tumor antigen p53Homo sapiens (human)
regulation of mitochondrial membrane permeability involved in apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of G1 to G0 transitionCellular tumor antigen p53Homo sapiens (human)
negative regulation of miRNA processingCellular tumor antigen p53Homo sapiens (human)
negative regulation of glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
negative regulation of pentose-phosphate shuntCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
regulation of fibroblast apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
positive regulation of cellular senescenceCellular tumor antigen p53Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
xenobiotic metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of glucose metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of steroid metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
intracellular receptor signaling pathwayNuclear receptor ROR-gammaHomo sapiens (human)
circadian regulation of gene expressionNuclear receptor ROR-gammaHomo sapiens (human)
cellular response to sterolNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of circadian rhythmNuclear receptor ROR-gammaHomo sapiens (human)
regulation of fat cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of DNA-templated transcriptionNuclear receptor ROR-gammaHomo sapiens (human)
adipose tissue developmentNuclear receptor ROR-gammaHomo sapiens (human)
T-helper 17 cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
inositol phosphate metabolic processInositol hexakisphosphate kinase 1Homo sapiens (human)
phosphatidylinositol phosphate biosynthetic processInositol hexakisphosphate kinase 1Homo sapiens (human)
negative regulation of cold-induced thermogenesisInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol phosphate biosynthetic processInositol hexakisphosphate kinase 1Homo sapiens (human)
cell population proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of B cell proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
nuclear DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
signal transduction in response to DNA damageATPase family AAA domain-containing protein 5Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
isotype switchingATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of isotype switching to IgG isotypesATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloadingATPase family AAA domain-containing protein 5Homo sapiens (human)
regulation of mitotic cell cycle phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of cell cycle G2/M phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of receptor internalizationAtaxin-2Homo sapiens (human)
regulation of translationAtaxin-2Homo sapiens (human)
RNA metabolic processAtaxin-2Homo sapiens (human)
P-body assemblyAtaxin-2Homo sapiens (human)
stress granule assemblyAtaxin-2Homo sapiens (human)
RNA transportAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (69)

Processvia Protein(s)Taxonomy
cytokine activityInterferon betaHomo sapiens (human)
cytokine receptor bindingInterferon betaHomo sapiens (human)
type I interferon receptor bindingInterferon betaHomo sapiens (human)
protein bindingInterferon betaHomo sapiens (human)
chloramphenicol O-acetyltransferase activityInterferon betaHomo sapiens (human)
TAP bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
signaling receptor bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
protein bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
peptide antigen bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
TAP bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
protein-folding chaperone bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
transcription cis-regulatory region bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
core promoter sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
TFIID-class transcription factor complex bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
protease bindingCellular tumor antigen p53Homo sapiens (human)
p53 bindingCellular tumor antigen p53Homo sapiens (human)
DNA bindingCellular tumor antigen p53Homo sapiens (human)
chromatin bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activityCellular tumor antigen p53Homo sapiens (human)
mRNA 3'-UTR bindingCellular tumor antigen p53Homo sapiens (human)
copper ion bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingCellular tumor antigen p53Homo sapiens (human)
zinc ion bindingCellular tumor antigen p53Homo sapiens (human)
enzyme bindingCellular tumor antigen p53Homo sapiens (human)
receptor tyrosine kinase bindingCellular tumor antigen p53Homo sapiens (human)
ubiquitin protein ligase bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase regulator activityCellular tumor antigen p53Homo sapiens (human)
ATP-dependent DNA/DNA annealing activityCellular tumor antigen p53Homo sapiens (human)
identical protein bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase bindingCellular tumor antigen p53Homo sapiens (human)
protein heterodimerization activityCellular tumor antigen p53Homo sapiens (human)
protein-folding chaperone bindingCellular tumor antigen p53Homo sapiens (human)
protein phosphatase 2A bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCellular tumor antigen p53Homo sapiens (human)
14-3-3 protein bindingCellular tumor antigen p53Homo sapiens (human)
MDM2/MDM4 family protein bindingCellular tumor antigen p53Homo sapiens (human)
disordered domain specific bindingCellular tumor antigen p53Homo sapiens (human)
general transcription initiation factor bindingCellular tumor antigen p53Homo sapiens (human)
molecular function activator activityCellular tumor antigen p53Homo sapiens (human)
promoter-specific chromatin bindingCellular tumor antigen p53Homo sapiens (human)
3'-5'-RNA exonuclease activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
RNA-dependent RNA polymerase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
cysteine-type endopeptidase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
mRNA 5'-cap (guanine-N7-)-methyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
mRNA (nucleoside-2'-O-)-methyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
mRNA guanylyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
RNA endonuclease activity, producing 3'-phosphomonoestersReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
ISG15-specific peptidase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
5'-3' RNA helicase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
protein guanylyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
RNA polymerase II cis-regulatory region sequence-specific DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
protein bindingNuclear receptor ROR-gammaHomo sapiens (human)
oxysterol bindingNuclear receptor ROR-gammaHomo sapiens (human)
zinc ion bindingNuclear receptor ROR-gammaHomo sapiens (human)
ligand-activated transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
sequence-specific double-stranded DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
nuclear receptor activityNuclear receptor ROR-gammaHomo sapiens (human)
inositol-1,3,4,5,6-pentakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol heptakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate 5-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
protein bindingInositol hexakisphosphate kinase 1Homo sapiens (human)
ATP bindingInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate 1-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate 3-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol 5-diphosphate pentakisphosphate 5-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol diphosphate tetrakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
protein bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP hydrolysis activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloader activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
RNA bindingAtaxin-2Homo sapiens (human)
epidermal growth factor receptor bindingAtaxin-2Homo sapiens (human)
protein bindingAtaxin-2Homo sapiens (human)
mRNA bindingAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (43)

Processvia Protein(s)Taxonomy
extracellular spaceInterferon betaHomo sapiens (human)
extracellular regionInterferon betaHomo sapiens (human)
Golgi membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
endoplasmic reticulumHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
Golgi apparatusHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
plasma membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
cell surfaceHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
ER to Golgi transport vesicle membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
secretory granule membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
phagocytic vesicle membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
early endosome membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
recycling endosome membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
extracellular exosomeHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
lumenal side of endoplasmic reticulum membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
MHC class I protein complexHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
extracellular spaceHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
external side of plasma membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
nuclear bodyCellular tumor antigen p53Homo sapiens (human)
nucleusCellular tumor antigen p53Homo sapiens (human)
nucleoplasmCellular tumor antigen p53Homo sapiens (human)
replication forkCellular tumor antigen p53Homo sapiens (human)
nucleolusCellular tumor antigen p53Homo sapiens (human)
cytoplasmCellular tumor antigen p53Homo sapiens (human)
mitochondrionCellular tumor antigen p53Homo sapiens (human)
mitochondrial matrixCellular tumor antigen p53Homo sapiens (human)
endoplasmic reticulumCellular tumor antigen p53Homo sapiens (human)
centrosomeCellular tumor antigen p53Homo sapiens (human)
cytosolCellular tumor antigen p53Homo sapiens (human)
nuclear matrixCellular tumor antigen p53Homo sapiens (human)
PML bodyCellular tumor antigen p53Homo sapiens (human)
transcription repressor complexCellular tumor antigen p53Homo sapiens (human)
site of double-strand breakCellular tumor antigen p53Homo sapiens (human)
germ cell nucleusCellular tumor antigen p53Homo sapiens (human)
chromatinCellular tumor antigen p53Homo sapiens (human)
transcription regulator complexCellular tumor antigen p53Homo sapiens (human)
protein-containing complexCellular tumor antigen p53Homo sapiens (human)
double membrane vesicle viral factory outer membraneReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
nucleoplasmNuclear receptor ROR-gammaHomo sapiens (human)
nuclear bodyNuclear receptor ROR-gammaHomo sapiens (human)
chromatinNuclear receptor ROR-gammaHomo sapiens (human)
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
virion membraneSpike glycoproteinSevere acute respiratory syndrome-related coronavirus
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
fibrillar centerInositol hexakisphosphate kinase 1Homo sapiens (human)
nucleoplasmInositol hexakisphosphate kinase 1Homo sapiens (human)
cytosolInositol hexakisphosphate kinase 1Homo sapiens (human)
nucleusInositol hexakisphosphate kinase 1Homo sapiens (human)
cytoplasmInositol hexakisphosphate kinase 1Homo sapiens (human)
Elg1 RFC-like complexATPase family AAA domain-containing protein 5Homo sapiens (human)
nucleusATPase family AAA domain-containing protein 5Homo sapiens (human)
cytoplasmAtaxin-2Homo sapiens (human)
Golgi apparatusAtaxin-2Homo sapiens (human)
trans-Golgi networkAtaxin-2Homo sapiens (human)
cytosolAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
membraneAtaxin-2Homo sapiens (human)
perinuclear region of cytoplasmAtaxin-2Homo sapiens (human)
ribonucleoprotein complexAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (109)

Assay IDTitleYearJournalArticle
AID1091824Antifungal activity against Curvularia sp. assessed as inhibition of spore germination at 0.5% after 24 hr by compound microscopy2009Pakistan journal of biological sciences : PJBS, Aug-15, Volume: 12, Issue:16
Implementation of bio-fungicides and seed treatment in organic rice cv. KDML 105 farming.
AID1091829Antifungal activity against Rhizoctonia solani assessed as inhibition of spore germination at 0.25% after 24 hr by compound microscopy2009Pakistan journal of biological sciences : PJBS, Aug-15, Volume: 12, Issue:16
Implementation of bio-fungicides and seed treatment in organic rice cv. KDML 105 farming.
AID1102096Antifungal activity against Diaporthe ampelina assessed as growth inhibition at 30 to 300 uM after 120 hr by microplate photometric analysis2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Natural fungicides from Ruta graveolens L. leaves, including a new quinolone alkaloid.
AID1091822Antifungal activity against Alternaria solani assessed as inhibition of spore germination at 1% after 24 hr by compound microscopy2009Pakistan journal of biological sciences : PJBS, Aug-15, Volume: 12, Issue:16
Implementation of bio-fungicides and seed treatment in organic rice cv. KDML 105 farming.
AID1091833Antifungal activity against Aspergillus flavus assessed as inhibition of spore germination at 0.25% after 24 hr by compound microscopy2009Pakistan journal of biological sciences : PJBS, Aug-15, Volume: 12, Issue:16
Implementation of bio-fungicides and seed treatment in organic rice cv. KDML 105 farming.
AID1091839Antifungal activity against Aspergillus flavus assessed as inhibition of spore germination at 0.10% after 24 hr by compound microscopy2009Pakistan journal of biological sciences : PJBS, Aug-15, Volume: 12, Issue:16
Implementation of bio-fungicides and seed treatment in organic rice cv. KDML 105 farming.
AID1090803Antifungal activity against Colletotrichum acutatum assessed as size of growth inhibitory zone at concentration of 2 mM in volume of 2 ul of EtOH measured after 4 days by TLC based direct bioautography assay2007Journal of agricultural and food chemistry, Oct-17, Volume: 55, Issue:21
Chemical composition and antifungal activity of Arnica longifolia, Aster hesperius, and Chrysothamnus nauseosus essential oils.
AID1091181Antifungal activity against Botryotinia fuckeliana assessed as inhibition of fungal growth measured after 72 hr by 96-well microdilution assay2008Journal of agricultural and food chemistry, Jul-09, Volume: 56, Issue:13
Isolation and identification of antifungal fatty acids from the basidiomycete Gomphus floccosus.
AID297552Fungistatic activity against Fusarium solani at 30 uM after 72 hrs by microtiter plate assay2007Journal of medicinal chemistry, Sep-06, Volume: 50, Issue:18
Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies.
AID1091203Antifungal activity against Colletotrichum gloeosporioides assessed as inhibition of fungal growth measured after 48 hr by 96-well microdilution assay2008Journal of agricultural and food chemistry, Jul-09, Volume: 56, Issue:13
Isolation and identification of antifungal fatty acids from the basidiomycete Gomphus floccosus.
AID1091853Antifungal activity against Bipolaris oryzae assessed as mycelial growth inhibition after 96 hr by agar overlay method2009Pakistan journal of biological sciences : PJBS, Aug-15, Volume: 12, Issue:16
Implementation of bio-fungicides and seed treatment in organic rice cv. KDML 105 farming.
AID1090337Antifungal activity against Colletotrichum acutatum after 72 hr by 96-well microtiter based microdilution method2006Journal of agricultural and food chemistry, Mar-08, Volume: 54, Issue:5
Antifungal activity of thiophenes from Echinops ritro.
AID1090334Antifungal activity against Fusarium oxysporum after 72 hr by 96-well microtiter based microdilution method2006Journal of agricultural and food chemistry, Mar-08, Volume: 54, Issue:5
Antifungal activity of thiophenes from Echinops ritro.
AID1091851Antifungal activity against Fusarium verticillioides assessed as mycelial growth inhibition after 96 hr by agar overlay method2009Pakistan journal of biological sciences : PJBS, Aug-15, Volume: 12, Issue:16
Implementation of bio-fungicides and seed treatment in organic rice cv. KDML 105 farming.
AID1091819Antifungal activity against Fusarium verticillioides assessed as inhibition of spore germination at 1% after 24 hr by compound microscopy2009Pakistan journal of biological sciences : PJBS, Aug-15, Volume: 12, Issue:16
Implementation of bio-fungicides and seed treatment in organic rice cv. KDML 105 farming.
AID1091836Antifungal activity against Curvularia sp. assessed as inhibition of spore germination at 0.10% after 24 hr by compound microscopy2009Pakistan journal of biological sciences : PJBS, Aug-15, Volume: 12, Issue:16
Implementation of bio-fungicides and seed treatment in organic rice cv. KDML 105 farming.
AID297517Antimicrobial activity against Fusarium solani at 0.3 uM after 48 hrs by microtiter assay2007Journal of medicinal chemistry, Sep-06, Volume: 50, Issue:18
Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies.
AID1090342Antifungal activity against Phomopsis obscurans after 48 hr by 96-well microtiter based microdilution method2006Journal of agricultural and food chemistry, Mar-08, Volume: 54, Issue:5
Antifungal activity of thiophenes from Echinops ritro.
AID297546Antimicrobial activity against Fusarium proliferatum at 3 uM after 48 hrs by microtiter assay2007Journal of medicinal chemistry, Sep-06, Volume: 50, Issue:18
Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies.
AID1090333Antifungal activity against Botryotinia fuckeliana after 72 hr by 96-well microtiter based microdilution method2006Journal of agricultural and food chemistry, Mar-08, Volume: 54, Issue:5
Antifungal activity of thiophenes from Echinops ritro.
AID297516Antimicrobial activity against Fusarium oxysporum at 0.3 uM after 72 hrs by microtiter assay2007Journal of medicinal chemistry, Sep-06, Volume: 50, Issue:18
Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies.
AID297555Fungistatic activity against Fusarium oxysporum at 30 uM after 72 hrs by microtiter plate assay2007Journal of medicinal chemistry, Sep-06, Volume: 50, Issue:18
Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies.
AID297515Antimicrobial activity against Fusarium oxysporum at 0.3 uM after 48 hrs by microtiter assay2007Journal of medicinal chemistry, Sep-06, Volume: 50, Issue:18
Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies.
AID1091825Antifungal activity against Fusarium verticillioides assessed as inhibition of spore germination at 0.5% after 24 hr by compound microscopy2009Pakistan journal of biological sciences : PJBS, Aug-15, Volume: 12, Issue:16
Implementation of bio-fungicides and seed treatment in organic rice cv. KDML 105 farming.
AID1090346Antifungal activity against Colletotrichum gloeosporioides after 48 hr by 96-well microtiter based microdilution method2006Journal of agricultural and food chemistry, Mar-08, Volume: 54, Issue:5
Antifungal activity of thiophenes from Echinops ritro.
AID1091855Antifungal activity against Aspergillus flavus assessed as mycelial growth inhibition after 96 hr by agar overlay method2009Pakistan journal of biological sciences : PJBS, Aug-15, Volume: 12, Issue:16
Implementation of bio-fungicides and seed treatment in organic rice cv. KDML 105 farming.
AID1091837Antifungal activity against Fusarium verticillioides assessed as inhibition of spore germination at 0.10% after 24 hr by compound microscopy2009Pakistan journal of biological sciences : PJBS, Aug-15, Volume: 12, Issue:16
Implementation of bio-fungicides and seed treatment in organic rice cv. KDML 105 farming.
AID1091849Antifungal activity against Rhizoctonia solani assessed as mycelial growth inhibition after 96 hr by agar overlay method2009Pakistan journal of biological sciences : PJBS, Aug-15, Volume: 12, Issue:16
Implementation of bio-fungicides and seed treatment in organic rice cv. KDML 105 farming.
AID376577Antifungal activity against Colletotrichum fragariae assessed as zone of inhibition2000Journal of natural products, Aug, Volume: 63, Issue:8
A new 2D-TLC bioautography method for the discovery of novel antifungal agents To control plant pathogens.
AID1091831Antifungal activity against Fusarium verticillioides assessed as inhibition of spore germination at 0.25% after 24 hr by compound microscopy2009Pakistan journal of biological sciences : PJBS, Aug-15, Volume: 12, Issue:16
Implementation of bio-fungicides and seed treatment in organic rice cv. KDML 105 farming.
AID1102099Antifungal activity against Phomopsis obscurans assessed as growth inhibition at 30 to 300 uM after 120 hr by microplate photometric analysis2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Natural fungicides from Ruta graveolens L. leaves, including a new quinolone alkaloid.
AID1102109Antifungal activity against Fusarium oxysporum assessed as growth inhibition at 300 uM after 48 hr by microplate photometric analysis2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Natural fungicides from Ruta graveolens L. leaves, including a new quinolone alkaloid.
AID1090506Antifungal activity against Colletotrichum fragariae assessed as growth inhibition at 2 uL in 2 mM acetone by direct bioautography2006Journal of agricultural and food chemistry, Sep-06, Volume: 54, Issue:18
Chemical composition and antifungal activity of Salvia macrochlamys and Salvia recognita essential oils.
AID1091198Antifungal activity against Phomopsis obscurans assessed as inhibition of fungal growth measured after 120 hr by 96-well microdilution assay2008Journal of agricultural and food chemistry, Jul-09, Volume: 56, Issue:13
Isolation and identification of antifungal fatty acids from the basidiomycete Gomphus floccosus.
AID1091823Antifungal activity against Rhizoctonia solani assessed as inhibition of spore germination at 0.5% after 24 hr by compound microscopy2009Pakistan journal of biological sciences : PJBS, Aug-15, Volume: 12, Issue:16
Implementation of bio-fungicides and seed treatment in organic rice cv. KDML 105 farming.
AID297523Antimicrobial activity against Fusarium oxysporum at 30 uM after 48 hrs by microtiter assay2007Journal of medicinal chemistry, Sep-06, Volume: 50, Issue:18
Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies.
AID1103657Growth inhibition of Fusarium oxysporum at 300 uM after 48 hr by microtiter assay2007The Alkaloids. Chemistry and biology, , Volume: 64Alkyl, aryl, alkylarylquinoline, and related alkaloids.
AID1091830Antifungal activity against Curvularia sp. assessed as inhibition of spore germination at 0.25% after 24 hr by compound microscopy2009Pakistan journal of biological sciences : PJBS, Aug-15, Volume: 12, Issue:16
Implementation of bio-fungicides and seed treatment in organic rice cv. KDML 105 farming.
AID297519Antimicrobial activity against Fusarium oxysporum at 3 uM after 48 hrs by microtiter assay2007Journal of medicinal chemistry, Sep-06, Volume: 50, Issue:18
Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies.
AID1091178Antifungal activity against Colletotrichum gloeosporioides assessed as inhibition of fungal growth measured after 72 hr by 96-well microdilution assay2008Journal of agricultural and food chemistry, Jul-09, Volume: 56, Issue:13
Isolation and identification of antifungal fatty acids from the basidiomycete Gomphus floccosus.
AID1080484Antifungal activity against Colletotrichum gloeosporioides assessed as inhibition of fungal growth at 2 mM in 2 uL solution by direct bio-autography assay2009Journal of agricultural and food chemistry, Jan-28, Volume: 57, Issue:2
Bioactivity-guided fractionation and GC/MS fingerprinting of Angelica sinensis and Angelica archangelica root components for antifungal and mosquito deterrent activity.
AID1090798Antifungal activity against Colletotrichum gloeosporioides assessed as size of growth inhibitory zone at concentration of 2 mM in volume of 2 ul of EtOH measured after 4 days by TLC based direct bioautography assay2007Journal of agricultural and food chemistry, Oct-17, Volume: 55, Issue:21
Chemical composition and antifungal activity of Arnica longifolia, Aster hesperius, and Chrysothamnus nauseosus essential oils.
AID1091177Antifungal activity against Fusarium oxysporum assessed as inhibition of fungal growth measured after 72 hr by 96-well microdilution assay2008Journal of agricultural and food chemistry, Jul-09, Volume: 56, Issue:13
Isolation and identification of antifungal fatty acids from the basidiomycete Gomphus floccosus.
AID1080486Antifungal activity against Colletotrichum acutatum assessed as inhibition of fungal growth at 2 mM in 2 uL solution by direct bio-autography assay2009Journal of agricultural and food chemistry, Jan-28, Volume: 57, Issue:2
Bioactivity-guided fractionation and GC/MS fingerprinting of Angelica sinensis and Angelica archangelica root components for antifungal and mosquito deterrent activity.
AID1091200Antifungal activity against Colletotrichum acutatum assessed as inhibition of fungal growth measured after 48 hr by 96-well microdilution assay2008Journal of agricultural and food chemistry, Jul-09, Volume: 56, Issue:13
Isolation and identification of antifungal fatty acids from the basidiomycete Gomphus floccosus.
AID297544Antimicrobial activity against Fusarium proliferatum at 0.3 uM after 48 hrs by microtiter assay2007Journal of medicinal chemistry, Sep-06, Volume: 50, Issue:18
Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies.
AID297521Antimicrobial activity against Fusarium solani at 3 uM after 48 hrs by microtiter assay2007Journal of medicinal chemistry, Sep-06, Volume: 50, Issue:18
Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies.
AID1090340Antifungal activity against Fusarium oxysporum after 48 hr by 96-well microtiter based microdilution method2006Journal of agricultural and food chemistry, Mar-08, Volume: 54, Issue:5
Antifungal activity of thiophenes from Echinops ritro.
AID1091832Antifungal activity against Aspergillus niger assessed as inhibition of spore germination at 0.25% after 24 hr by compound microscopy2009Pakistan journal of biological sciences : PJBS, Aug-15, Volume: 12, Issue:16
Implementation of bio-fungicides and seed treatment in organic rice cv. KDML 105 farming.
AID1090339Antifungal activity against Colletotrichum gloeosporioides after 72 hr by 96-well microtiter based microdilution method2006Journal of agricultural and food chemistry, Mar-08, Volume: 54, Issue:5
Antifungal activity of thiophenes from Echinops ritro.
AID1091846Antifungal activity against Aspergillus niger assessed as mycelial growth inhibition at 1% after 96 hr by agar overlay method2009Pakistan journal of biological sciences : PJBS, Aug-15, Volume: 12, Issue:16
Implementation of bio-fungicides and seed treatment in organic rice cv. KDML 105 farming.
AID297550Fungistatic activity against Fusarium proliferatum at 30 uM after 72 hrs by microtiter plate assay2007Journal of medicinal chemistry, Sep-06, Volume: 50, Issue:18
Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies.
AID1080485Antifungal activity against Colletotrichum fragariae assessed as inhibition of fungal growth at 2 mM in 2 uL solution by direct bio-autography assay2009Journal of agricultural and food chemistry, Jan-28, Volume: 57, Issue:2
Bioactivity-guided fractionation and GC/MS fingerprinting of Angelica sinensis and Angelica archangelica root components for antifungal and mosquito deterrent activity.
AID1090345Antifungal activity against Colletotrichum acutatum after 48 hr by 96-well microtiter based microdilution method2006Journal of agricultural and food chemistry, Mar-08, Volume: 54, Issue:5
Antifungal activity of thiophenes from Echinops ritro.
AID1090344Antifungal activity against Colletotrichum fragariae after 48 hr by 96-well microtiter based microdilution method2006Journal of agricultural and food chemistry, Mar-08, Volume: 54, Issue:5
Antifungal activity of thiophenes from Echinops ritro.
AID1091845Antifungal activity against Bipolaris oryzae assessed as mycelial growth inhibition at 1% after 96 hr by agar overlay method2009Pakistan journal of biological sciences : PJBS, Aug-15, Volume: 12, Issue:16
Implementation of bio-fungicides and seed treatment in organic rice cv. KDML 105 farming.
AID1090505Antifungal activity against Colletotrichum acutatum assessed as growth inhibition at 2 uL in 2 mM acetone by direct bioautography2006Journal of agricultural and food chemistry, Sep-06, Volume: 54, Issue:18
Chemical composition and antifungal activity of Salvia macrochlamys and Salvia recognita essential oils.
AID1091848Antifungal activity against Alternaria solani assessed as mycelial growth inhibition at 1% after 96 hr by agar overlay method2009Pakistan journal of biological sciences : PJBS, Aug-15, Volume: 12, Issue:16
Implementation of bio-fungicides and seed treatment in organic rice cv. KDML 105 farming.
AID1091834Antifungal activity against Alternaria solani assessed as inhibition of spore germination at 0.25% after 24 hr by compound microscopy2009Pakistan journal of biological sciences : PJBS, Aug-15, Volume: 12, Issue:16
Implementation of bio-fungicides and seed treatment in organic rice cv. KDML 105 farming.
AID297545Antimicrobial activity against Fusarium proliferatum at 0.3 uM after 72 hrs by microtiter assay2007Journal of medicinal chemistry, Sep-06, Volume: 50, Issue:18
Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies.
AID297549Antimicrobial activity against Fusarium proliferatum at 30 uM after 72 hrs by microtiter assay2007Journal of medicinal chemistry, Sep-06, Volume: 50, Issue:18
Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies.
AID1091197Antifungal activity against Plasmopara viticola assessed as inhibition of fungal growth measured after 120 hr by 96-well microdilution assay2008Journal of agricultural and food chemistry, Jul-09, Volume: 56, Issue:13
Isolation and identification of antifungal fatty acids from the basidiomycete Gomphus floccosus.
AID1091202Antifungal activity against Colletotrichum fragariae assessed as inhibition of fungal growth measured after 48 hr by 96-well microdilution assay2008Journal of agricultural and food chemistry, Jul-09, Volume: 56, Issue:13
Isolation and identification of antifungal fatty acids from the basidiomycete Gomphus floccosus.
AID297526Antimicrobial activity against Fusarium solani at 30 uM after 72 hrs by microtiter assay2007Journal of medicinal chemistry, Sep-06, Volume: 50, Issue:18
Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies.
AID1091817Antifungal activity against Rhizoctonia solani assessed as inhibition of spore germination at 1% after 24 hr by compound microscopy2009Pakistan journal of biological sciences : PJBS, Aug-15, Volume: 12, Issue:16
Implementation of bio-fungicides and seed treatment in organic rice cv. KDML 105 farming.
AID1091199Antifungal activity against Fusarium oxysporum assessed as inhibition of fungal growth measured after 48 hr by 96-well microdilution assay2008Journal of agricultural and food chemistry, Jul-09, Volume: 56, Issue:13
Isolation and identification of antifungal fatty acids from the basidiomycete Gomphus floccosus.
AID1091844Antifungal activity against Curvularia sp. assessed as mycelial growth inhibition at 1% after 96 hr by agar overlay method2009Pakistan journal of biological sciences : PJBS, Aug-15, Volume: 12, Issue:16
Implementation of bio-fungicides and seed treatment in organic rice cv. KDML 105 farming.
AID297524Antimicrobial activity against Fusarium oxysporum at 30 uM after 72 hrs by microtiter assay2007Journal of medicinal chemistry, Sep-06, Volume: 50, Issue:18
Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies.
AID1091821Antifungal activity against Aspergillus flavus assessed as inhibition of spore germination at 1% after 24 hr by compound microscopy2009Pakistan journal of biological sciences : PJBS, Aug-15, Volume: 12, Issue:16
Implementation of bio-fungicides and seed treatment in organic rice cv. KDML 105 farming.
AID1090338Antifungal activity against Colletotrichum fragariae after 72 hr by 96-well microtiter based microdilution method2006Journal of agricultural and food chemistry, Mar-08, Volume: 54, Issue:5
Antifungal activity of thiophenes from Echinops ritro.
AID1091835Antifungal activity against Rhizoctonia solani assessed as inhibition of spore germination at 0.10% after 24 hr by compound microscopy2009Pakistan journal of biological sciences : PJBS, Aug-15, Volume: 12, Issue:16
Implementation of bio-fungicides and seed treatment in organic rice cv. KDML 105 farming.
AID1091838Antifungal activity against Aspergillus niger assessed as inhibition of spore germination at 0.10% after 24 hr by compound microscopy2009Pakistan journal of biological sciences : PJBS, Aug-15, Volume: 12, Issue:16
Implementation of bio-fungicides and seed treatment in organic rice cv. KDML 105 farming.
AID1091856Antifungal activity against Alternaria solani assessed as mycelial growth inhibition after 96 hr by agar overlay method2009Pakistan journal of biological sciences : PJBS, Aug-15, Volume: 12, Issue:16
Implementation of bio-fungicides and seed treatment in organic rice cv. KDML 105 farming.
AID1090336Antifungal activity against Plasmopara viticola after 72 hr by 96-well microtiter based microdilution method2006Journal of agricultural and food chemistry, Mar-08, Volume: 54, Issue:5
Antifungal activity of thiophenes from Echinops ritro.
AID1081601Fungicidal activity against Botryotinia fuckeliana assessed as growth inhibition at 10 to 100 uM after 72 hr by microbioassay2010Journal of agricultural and food chemistry, Sep-08, Volume: 58, Issue:17
New class of algicidal compounds and fungicidal activities derived from a chromene amide of Amyris texana.
AID1090341Antifungal activity against Botryotinia fuckeliana after 48 hr by 96-well microtiter based microdilution method2006Journal of agricultural and food chemistry, Mar-08, Volume: 54, Issue:5
Antifungal activity of thiophenes from Echinops ritro.
AID1091820Antifungal activity against Aspergillus niger assessed as inhibition of spore germination at 1% after 24 hr by compound microscopy2009Pakistan journal of biological sciences : PJBS, Aug-15, Volume: 12, Issue:16
Implementation of bio-fungicides and seed treatment in organic rice cv. KDML 105 farming.
AID1091841Antifungal activity against Rhizoctonia solani assessed as mycelial growth inhibition at 1% after 96 hr by agar overlay method2009Pakistan journal of biological sciences : PJBS, Aug-15, Volume: 12, Issue:16
Implementation of bio-fungicides and seed treatment in organic rice cv. KDML 105 farming.
AID1091180Antifungal activity against Colletotrichum acutatum assessed as inhibition of fungal growth measured after 72 hr by 96-well microdilution assay2008Journal of agricultural and food chemistry, Jul-09, Volume: 56, Issue:13
Isolation and identification of antifungal fatty acids from the basidiomycete Gomphus floccosus.
AID1091852Antifungal activity against Curvularia sp. assessed as mycelial growth inhibition after 96 hr by agar overlay method2009Pakistan journal of biological sciences : PJBS, Aug-15, Volume: 12, Issue:16
Implementation of bio-fungicides and seed treatment in organic rice cv. KDML 105 farming.
AID1091840Antifungal activity against Alternaria solani assessed as inhibition of spore germination at 0.10% after 24 hr by compound microscopy2009Pakistan journal of biological sciences : PJBS, Aug-15, Volume: 12, Issue:16
Implementation of bio-fungicides and seed treatment in organic rice cv. KDML 105 farming.
AID1091818Antifungal activity against Curvularia sp. assessed as inhibition of spore germination at 1% after 24 hr by compound microscopy2009Pakistan journal of biological sciences : PJBS, Aug-15, Volume: 12, Issue:16
Implementation of bio-fungicides and seed treatment in organic rice cv. KDML 105 farming.
AID297547Antimicrobial activity against Fusarium proliferatum at 3 uM after 72 hrs by microtiter assay2007Journal of medicinal chemistry, Sep-06, Volume: 50, Issue:18
Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies.
AID297520Antimicrobial activity against Fusarium oxysporum at 3 uM after 72 hrs by microtiter assay2007Journal of medicinal chemistry, Sep-06, Volume: 50, Issue:18
Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies.
AID1091179Antifungal activity against Colletotrichum fragariae assessed as inhibition of fungal growth measured after 72 hr by 96-well microdilution assay2008Journal of agricultural and food chemistry, Jul-09, Volume: 56, Issue:13
Isolation and identification of antifungal fatty acids from the basidiomycete Gomphus floccosus.
AID1091842Antifungal activity against Nigrospora sp. assessed as mycelial growth inhibition at 1% after 96 hr by agar overlay method2009Pakistan journal of biological sciences : PJBS, Aug-15, Volume: 12, Issue:16
Implementation of bio-fungicides and seed treatment in organic rice cv. KDML 105 farming.
AID1091187Antifungal activity against Plasmopara viticola assessed as inhibition of fungal growth measured after 144 hr by 96-well microdilution assay2008Journal of agricultural and food chemistry, Jul-09, Volume: 56, Issue:13
Isolation and identification of antifungal fatty acids from the basidiomycete Gomphus floccosus.
AID1091201Antifungal activity against Botryotinia fuckeliana assessed as inhibition of fungal growth measured after 48 hr by 96-well microdilution assay2008Journal of agricultural and food chemistry, Jul-09, Volume: 56, Issue:13
Isolation and identification of antifungal fatty acids from the basidiomycete Gomphus floccosus.
AID1090504Antifungal activity against Colletotrichum gloeosporioides assessed as growth inhibition at 2 uL in 2 mM acetone by direct bioautography2006Journal of agricultural and food chemistry, Sep-06, Volume: 54, Issue:18
Chemical composition and antifungal activity of Salvia macrochlamys and Salvia recognita essential oils.
AID1091843Antifungal activity against Fusarium verticillioides assessed as mycelial growth inhibition at 1% after 96 hr by agar overlay method2009Pakistan journal of biological sciences : PJBS, Aug-15, Volume: 12, Issue:16
Implementation of bio-fungicides and seed treatment in organic rice cv. KDML 105 farming.
AID1090335Antifungal activity against Phomopsis obscurans after 72 hr by 96-well microtiter based microdilution method2006Journal of agricultural and food chemistry, Mar-08, Volume: 54, Issue:5
Antifungal activity of thiophenes from Echinops ritro.
AID1090343Antifungal activity against Plasmopara viticola after 48 hr by 96-well microtiter based microdilution method2006Journal of agricultural and food chemistry, Mar-08, Volume: 54, Issue:5
Antifungal activity of thiophenes from Echinops ritro.
AID1091826Antifungal activity against Aspergillus niger assessed as inhibition of spore germination at 0.5% after 24 hr by compound microscopy2009Pakistan journal of biological sciences : PJBS, Aug-15, Volume: 12, Issue:16
Implementation of bio-fungicides and seed treatment in organic rice cv. KDML 105 farming.
AID297525Antimicrobial activity against Fusarium solani at 30 uM after 48 hrs by microtiter assay2007Journal of medicinal chemistry, Sep-06, Volume: 50, Issue:18
Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies.
AID1091854Antifungal activity against Aspergillus niger assessed as mycelial growth inhibition after 96 hr by agar overlay method2009Pakistan journal of biological sciences : PJBS, Aug-15, Volume: 12, Issue:16
Implementation of bio-fungicides and seed treatment in organic rice cv. KDML 105 farming.
AID1091828Antifungal activity against Alternaria solani assessed as inhibition of spore germination at 0.5% after 24 hr by compound microscopy2009Pakistan journal of biological sciences : PJBS, Aug-15, Volume: 12, Issue:16
Implementation of bio-fungicides and seed treatment in organic rice cv. KDML 105 farming.
AID297548Antimicrobial activity against Fusarium proliferatum at 30 uM after 48 hrs by microtiter assay2007Journal of medicinal chemistry, Sep-06, Volume: 50, Issue:18
Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies.
AID1090142Antifungal activity against Cladosporium herbarum assessed as growth inhibition at 23 degC measured after 72 hr2005Journal of agricultural and food chemistry, Jan-26, Volume: 53, Issue:2
Antifungal and insect antifeedant 2-phenylethanol esters from the liverwort Balantiopsis cancellata from Chile.
AID1091847Antifungal activity against Aspergillus flavus assessed as mycelial growth inhibition at 1% after 96 hr by agar overlay method2009Pakistan journal of biological sciences : PJBS, Aug-15, Volume: 12, Issue:16
Implementation of bio-fungicides and seed treatment in organic rice cv. KDML 105 farming.
AID1090800Antifungal activity against Colletotrichum fragariae assessed as size of growth inhibitory zone at concentration of 2 mM in volume of 2 ul of EtOH measured after 4 days by TLC based direct bioautography assay2007Journal of agricultural and food chemistry, Oct-17, Volume: 55, Issue:21
Chemical composition and antifungal activity of Arnica longifolia, Aster hesperius, and Chrysothamnus nauseosus essential oils.
AID1091850Antifungal activity against Nigrospora sp. assessed as mycelial growth inhibition after 96 hr by agar overlay method2009Pakistan journal of biological sciences : PJBS, Aug-15, Volume: 12, Issue:16
Implementation of bio-fungicides and seed treatment in organic rice cv. KDML 105 farming.
AID1081918Antifungal activity against Diaporthe ampelina assessed as growth inhibition after 144 hr by NCCLS M27-A broth microdilution method2011Journal of agricultural and food chemistry, Mar-09, Volume: 59, Issue:5
Biological activity of peanut (Arachis hypogaea) phytoalexins and selected natural and synthetic Stilbenoids.
AID1091827Antifungal activity against Aspergillus flavus assessed as inhibition of spore germination at 0.5% after 24 hr by compound microscopy2009Pakistan journal of biological sciences : PJBS, Aug-15, Volume: 12, Issue:16
Implementation of bio-fungicides and seed treatment in organic rice cv. KDML 105 farming.
AID297518Antimicrobial activity against Fusarium solani at 0.3 uM after 72 hrs by microtiter assay2007Journal of medicinal chemistry, Sep-06, Volume: 50, Issue:18
Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies.
AID297522Antimicrobial activity against Fusarium solani at 3 uM after 72 hrs by microtiter assay2007Journal of medicinal chemistry, Sep-06, Volume: 50, Issue:18
Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies.
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (343)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990135 (39.36)18.7374
1990's62 (18.08)18.2507
2000's65 (18.95)29.6817
2010's55 (16.03)24.3611
2020's26 (7.58)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 60.51

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index60.51 (24.57)
Research Supply Index5.93 (2.92)
Research Growth Index4.50 (4.65)
Search Engine Demand Index135.21 (26.88)
Search Engine Supply Index2.63 (0.95)

This Compound (60.51)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials4 (1.07%)5.53%
Reviews13 (3.49%)6.00%
Case Studies10 (2.68%)4.05%
Observational0 (0.00%)0.25%
Other346 (92.76%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]